Success Stories: Research Associate in California in the Field of Cancer Research Has EB-1A Approved
Client’s Testimonial:
It is great news! Thank you very much for your help on my case!
Position at the Time of Case Filing: Research Associate
Country of Origin: China
Service Center: Nebraska Service Center (NSC)
State of Residence at the Time of Filing: California
Approval Notice Date: July 23, 2014
Processing Time: 20 days (2 days after requesting Premium Processing)
In this case, the client that we had the opportunity to work was a Research Associate from China in the field of Cancer Research. His specialized research had focused on the understanding of cancer suppressor protein p53, and, more recently, the IRE1α-XBP-1 pathway within the unfolded protein response (UPR). His work had resulted in 4 peer-reviewed scientific articles, 1 research highlight article, 5 presentations at national and international conferences, and 1 book chapter. At the time that his case was filed, his publications had been cited at least 194 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed 21 manuscripts for distinctive, internationally-circulated journals related to his field. His superior level of achievement was confirmed in the following quote from an independent recommender, “Therefore, [his] career is that of a truly exemplary member of the field. His work is centered in an area of intense global concern, has produced astonishing findings in said area, and he will continue to do so as long as his career is continued uninhibited. There are not many researchers with [his] level of skill combined with his proven record of salient findings, and so I offer my support of his research.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought remain in the United States to continue work in the area of extraordinary ability, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in just 20 days.